Strategic Report Welcome to Dechra Pharmaceuticals PLC The Global Market Opportunity Dechra's Strengths Highlights Our Business Model Our Business Model Explained Our Products Delivering Our Strategy Geographical Footprint Non-Executive Chairman's and Chief Executive Officer's Statement Financial Review Q&A with Ian Page Q&A with Richard Cotton Key Performance Indicators Strategy in Action Pipeline Delivery Portfolio Focus Geographical Expansion Acquisition Product Development International Product Offering Corporate Social Responsibility How the Business Manages Risk Understanding Our Key Risks Our Governance Letter from the Chairman on Governance Corporate Governance Letter from the Audit Committee Chairman Audit Committee Report Letter from the Nomination Committee Chairman Letter from the Remuneration Committee Chairman Directors' Remuneration Report Directors' Report - Other Disclosures Statement of Directors' Responsibilities Our Financials Independent Auditor's Report to the Members of Dechra Pharmaceuticals PLC Consolidated Income Statement Consolidated Statement of Comprehensive Income Consolidated Statement of Financial Position Consolidated Statement of Changes in Shareholders' Equity Consolidated Statement of Cash Flows Notes to the Consolidated Financial Statements Company Statement of Financial Position Company Statement of Changes in Shareholders' Equity Notes to the Company Financial Statements Financial History Shareholder Information Glossary Shareholder Information Advisers prev Advisers next Accessibility